LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 42 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q2 2022. The put-call ratio across all filers is - and the average weighting 2.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $183,000 | +64.9% | 57,500 | +120.3% | 0.00% | – |
| Q1 2022 | $111,000 | -32.7% | 26,100 | -26.5% | 0.00% | – |
| Q4 2021 | $165,000 | -9.8% | 35,500 | -22.5% | 0.00% | – |
| Q3 2021 | $183,000 | +28.9% | 45,836 | +36.4% | 0.00% | – |
| Q1 2021 | $142,000 | -71.8% | 33,600 | -74.1% | 0.00% | -100.0% |
| Q4 2020 | $504,000 | +1020.0% | 129,953 | +1070.7% | 0.00% | – |
| Q3 2020 | $45,000 | -94.9% | 11,100 | -94.6% | 0.00% | -100.0% |
| Q2 2020 | $876,000 | +26.6% | 205,733 | +726.3% | 0.00% | -50.0% |
| Q3 2015 | $692,000 | +133.8% | 24,898 | -9.1% | 0.00% | +100.0% |
| Q1 2014 | $296,000 | – | 27,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 240,000 | $1,027,000 | 95.09% |
| TANG CAPITAL MANAGEMENT LLC | 10,049,224 | $43,011,000 | 8.56% |
| RTW INVESTMENTS, LP | 2,327,903 | $9,963,000 | 0.15% |
| Boxer Capital, LLC | 890,700 | $3,812,000 | 0.13% |
| Tibra Equities Europe Ltd | 72,600 | $311,000 | 0.10% |
| WealthTrust Axiom LLC | 25,400 | $108,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 52,749 | $226,000 | 0.02% |
| FIRST MIDWEST BANK TRUST DIVISION | 34,231 | $147,000 | 0.02% |
| HOLLENCREST CAPITAL MANAGEMENT | 42,355 | $181,000 | 0.02% |
| Summit Global Investments | 48,500 | $208,000 | 0.01% |